Related Experiment Video

Updated: May 6, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K

Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2

Verónica Rivas, Rita Carmona, Ramón Muñoz-Chápuli

    The Journal of Clinical Investigation
    |October 19, 2013
    PubMed

    Insights

    G protein-coupled receptor kinase 2 (GRK2) is crucial for blood vessel formation and maturation. Its downregulation in endothelial cells promotes tumor growth and vascular dysfunction, suggesting GRK2 is a key player in the tumoral angiogenic switch.

    Area of Science:

    • Molecular Biology
    • Cancer Research
    • Vascular Biology

    Background:

    • Tumor vessel dysfunction is critical for cancer progression.
    • Angiogenesis, the formation of new blood vessels, is a complex process regulated by various factors.
    • The role of G protein-coupled receptor kinase 2 (GRK2) in angiogenesis is not fully understood.

    Purpose of the Study:

    • To investigate the role of GRK2 in regulating angiogenesis and tumor vascularization.
    • To determine the impact of GRK2 dysfunction on endothelial cell behavior and vessel maturation.
    • To explore the potential of GRK2 as a therapeutic target in cancer.

    Main Methods:

    • Utilized an in vivo neovascularization model in mice.
    • Generated mice with Grk2 hemizygosity or endothelium-specific Grk2 silencing.
    • Isolated endothelial cells (ECs) for functional assays (migration, TGF-β signaling, network formation).
    • Examined retinal vascular development and embryonic vascular malformations.
    • Assessed tumor growth, pericyte coverage, and immune cell infiltration in Grk2-deficient models.

    Main Results:

    • GRK2 is identified as a key regulator of angiogenesis.
    • Impaired angiogenic response and immature vessels were observed in Grk2-deficient models.
    • Endothelial Grk2 deficiency led to intrinsic defects in EC migration, TGF-β signaling, and network formation.
    • Systemic or endothelial Grk2 ablation caused significant vascular malformations and impaired mural cell recruitment.
    • Decreased endothelial GRK2 accelerated tumor growth, reduced pericyte coverage, and increased macrophage infiltration.
    • GRK2 downregulation was observed in tumor endothelial cells and human breast cancer vessels.

    Conclusions:

    • GRK2 plays a vital role in endothelial cell function, vessel maturation, and mural cell recruitment.
    • Downregulation of GRK2 contributes to tumor angiogenesis and vascular dysfunction.
    • GRK2 is a significant factor in the tumoral angiogenic switch and a potential therapeutic target.

    More Related Videos

    Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

    Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

    Published on: June 15, 2017

    8.0K
    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

    Published on: November 23, 2014

    9.2K

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
    2.9K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    3.6K
    Receptor Tyrosine Kinases01:26

    Receptor Tyrosine Kinases

    Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
    15.7K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    5.2K
    Amplifying Signals via Enzymatic Cascade01:22

    Amplifying Signals via Enzymatic Cascade

    When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
    15.3K
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
    2.0K